The Coca-Cola Company · KO · FY2025 Q4 · Calendar Q1 2026
Coca-Cola Reaffirms 2026 Growth Outlook as Portfolio Broadens
The supplied analysis supports a cautiously constructive view of Coca-Cola’s growth case: portfolio breadth, innovation, bottler alignment and a first-time 30% North America operating margin underpin management’s maintained outlook, while volume, currency and tax risks remain important tests.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about KO FY2025 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, management’s emphasis shifted to a broader 32-brand portfolio, a first-time 30% North America operating margin and the Coke Buddy digital platform, while 2026 guidance remained maintained. The key unresolved issues are price/mix versus volume, currency, Mexican tax effects and pending divestitures.
Guidance delta
Maintained: management reaffirmed 2026 guidance for 4–5% organic revenue growth and 7–8% EPS growth.
Key takeaways
- Management described 2025 as solid, with 5% organic revenue growth, $0.58 EPS and $11.4 billion in free cash flow.
- The portfolio now includes 32 billion-dollar brands, with 75% outside sparkling soft drinks.
- North America reached a 30% operating margin for the first time, supporting the profitability case.
- Growth plans emphasize innovation, digital engagement, bottler alignment and volume recovery in emerging markets.
Management priorities
- Launch additional billion-dollar brands and accelerate innovation.
- Scale the Coke Buddy digital platform and other AI-driven tools.
- Increase cold-drink equipment placement and refine price-pack architecture.
- Invest in fairlife, concentrate and finished-goods capacity.
- Use World Cup and other sports partnerships for promotional lift.
Follow KO with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Overweight | Maintain | Sep 28, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 30, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 29, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 29, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 29, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 29, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 29, 2026 |
| UBS | Buy | Buy | Maintain | Jul 16, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 14, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 10, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Apr 29, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Mar 30, 2026 |
| Freedom Broker | Hold | Hold | Maintain | Oct 31, 2025 |
| BNP Paribas | Outperform | Outperform | Maintain | Jul 21, 2025 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 9, 2025 |
| Truist Securities | Buy | Buy | Maintain | Oct 16, 2024 |
| CFRA | Hold | Buy | Downgrade | Sep 5, 2024 |
| Wedbush | Outperform | Outperform | Maintain | Jul 27, 2023 |
| HSBC | Buy | Buy | Maintain | Jun 7, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Oct 3, 2022 |
| DZ Bank | Hold | Buy | Downgrade | Apr 28, 2022 |
| Guggenheim | Buy | Buy | Maintain | Apr 26, 2022 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Apr 26, 2022 |
| DA Davidson | Perform | Peer Perform | Maintain | Apr 13, 2021 |
| Bernstein | Outperform | Outperform | Maintain | Jan 20, 2021 |
| Goldman Sachs | Neutral | Neutral | Maintain | Apr 1, 2020 |
| BMO Capital | Market Perform | Market Perform | Maintain | Oct 21, 2019 |
| Atlantic Equities | Overweight | Overweight | Maintain | Jul 29, 2019 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Bank of America | Buy | Buy | Maintain | Oct 9, 2017 |
| Daiwa Capital | Outperform | Outperform | Maintain | Jun 13, 2017 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Sep 29, 2016 |
| Stifel | Hold | Buy | Downgrade | Sep 29, 2016 |
| Susquehanna | Neutral | Neutral | Maintain | Mar 15, 2016 |
| Sterne Agee CRT | Neutral | Buy | Downgrade | Feb 26, 2016 |
| Sterne Agee | Neutral | Buy | Downgrade | Feb 26, 2016 |
| Tigress Financial | Neutral | Buy | Downgrade | Dec 4, 2015 |
| Nomura | Buy | Buy | Maintain | Dec 15, 2014 |
| Societe Generale | Sell | Hold | Downgrade | Oct 22, 2014 |
| Brasil Plural | Overweight | Overweight | Maintain | Aug 25, 2014 |
| Janney Capital | Buy | Buy | Maintain | Dec 12, 2013 |
| Standpoint Research | Sell | Sell | Maintain | Dec 2, 2013 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Sep 19, 2013 |
| CLSA | Underperform | Outperform | Downgrade | Sep 3, 2013 |
| Davenport | Neutral | Buy | Downgrade | Apr 12, 2013 |
| Credit Agricole | Outperform | Underperform | Upgrade | Mar 14, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $86.84. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Seaport Global | Analyst unavailable | $95 | $87.76 | +9.4% | Aug 14, 2026 |
| Barclays | Lauren Lieberman | $93 | $89.08 | +7.1% | Jul 30, 2026 |
| RBC Capital | Analyst unavailable | $96 | $90.39 | +10.5% | Jul 29, 2026 |
| UBS | Peter Grom | $104 | $90.12 | +19.8% | Jul 29, 2026 |
| Piper Sandler | Analyst unavailable | $95 | $88.27 | +9.4% | Jul 29, 2026 |
| Jefferies | Kaumil Gajrawala | $104 | $88.27 | +19.8% | Jul 29, 2026 |
| Wells Fargo | Analyst unavailable | $95 | $88.27 | +9.4% | Jul 29, 2026 |
| Bernstein | Cristian Rios | $93 | $88.27 | +7.1% | Jul 29, 2026 |
| Morgan Stanley | Dara Mohsenian | $100 | $88.27 | +15.2% | Jul 29, 2026 |
| Goldman Sachs | Analyst unavailable | $86 | $88.27 | -1.0% | Jul 28, 2026 |
| Evercore ISI | Analyst unavailable | $100 | $88.29 | +15.2% | Jul 28, 2026 |
| Barclays | Lauren Lieberman | $91 | $82.12 | +4.8% | Jul 21, 2026 |
| UBS | Peter Grom | $98 | $84.57 | +12.9% | Jul 16, 2026 |
| Bernstein | Analyst unavailable | $83 | $82.46 | -4.4% | Jul 9, 2026 |
| Truist Financial | Analyst unavailable | $88 | $81.42 | +1.3% | Jun 26, 2026 |
| Bernstein | Cristian Rios | $84 | $82.53 | -3.3% | Jun 11, 2026 |
| Morgan Stanley | Dara Mohsenian | $89 | $81.34 | +2.5% | Jun 10, 2026 |
| Barclays | Analyst unavailable | $89 | $81.55 | +2.5% | May 21, 2026 |
| Barclays | Analyst unavailable | $85 | $78.87 | -2.1% | Apr 30, 2026 |
| Morgan Stanley | Analyst unavailable | $88 | $77.58 | +1.3% | Mar 11, 2026 |
| Barclays | Analyst unavailable | $83 | $79.56 | -4.4% | Feb 12, 2026 |
| Truist Financial | Analyst unavailable | $85 | $78.32 | -2.1% | Feb 11, 2026 |
| UBS | Analyst unavailable | $87 | $78.17 | +0.2% | Feb 11, 2026 |
| Morgan Stanley | Analyst unavailable | $87 | $77.33 | +0.2% | Feb 11, 2026 |
| RBC Capital | Nik Modi | $87 | $78.27 | +0.2% | Feb 11, 2026 |
| Evercore ISI | Analyst unavailable | $85 | $77.66 | -2.1% | Feb 11, 2026 |
| RBC Capital | Nik Modi | $78 | $78.52 | -10.2% | Feb 6, 2026 |
| UBS | Peter Grom | $82 | $76.96 | -5.6% | Feb 3, 2026 |
| Deutsche Bank | Analyst unavailable | $83 | $73.52 | -4.4% | Jan 29, 2026 |
| Barclays | Lauren Lieberman | $77 | $70.4 | -11.3% | Oct 23, 2025 |
| Piper Sandler | Analyst unavailable | $81 | $71.22 | -6.7% | Oct 22, 2025 |
| Evercore ISI | Analyst unavailable | $82 | $71.22 | -5.6% | Oct 21, 2025 |
| RBC Capital | Nik Modi | $76 | $70.44 | -12.5% | Jul 21, 2025 |
| Jefferies | Kaumil Gajrawala | $77 | $68.01 | -11.3% | Oct 24, 2024 |
| CFRA | Garrett Nelson | $70 | $67.6 | -19.4% | Oct 23, 2024 |
| Morgan Stanley | Dara Mohsenian | $78 | $70.84 | -10.2% | Aug 27, 2024 |
| Truist Financial | Bill Chappell | $70 | $65.81 | -19.4% | Jul 25, 2024 |
| Argus Research | Christopher Graja | $72 | $62.94 | -17.1% | May 22, 2024 |
| D.A. Davidson | Linda Bolton Weiser | $81 | $28.7 | -6.7% | Nov 21, 2023 |
| Bernstein | Callum Elliott | $66 | $63.98 | -24.0% | Apr 25, 2023 |
| Morgan Stanley | Dara Mohsenian | $70 | $60.36 | -19.4% | Mar 7, 2023 |
| Wells Fargo | Chris Carey | $70 | $60.6 | -19.4% | Feb 14, 2023 |
| Deutsche Bank | Analyst unavailable | $62 | $63.68 | -28.6% | Dec 6, 2022 |
| Wedbush | Gerald Pascarelli | $63 | $54.39 | -27.5% | Oct 10, 2022 |
| HSBC | Analyst unavailable | $76 | $61.15 | -12.5% | Sep 6, 2022 |
| Deutsche Bank | Analyst unavailable | $65 | $62.51 | -25.1% | Jul 27, 2022 |
| UBS | Analyst unavailable | $72 | $63.21 | -17.1% | Jul 27, 2022 |
| Truist Financial | Bill Chappell | $75 | $65.56 | -13.6% | Apr 27, 2022 |
| Wells Fargo | Chris Carey | $74 | $66.15 | -14.8% | Apr 27, 2022 |
| Guggenheim | Analyst unavailable | $71 | $65.46 | -18.2% | Apr 26, 2022 |
| Deutsche Bank | Analyst unavailable | $64 | $65.81 | -26.3% | Apr 26, 2022 |
| Credit Suisse | Analyst unavailable | $68 | $65.81 | -21.7% | Apr 26, 2022 |
| HSBC | Analyst unavailable | $72 | $65.57 | -17.1% | Apr 26, 2022 |
| Citigroup | Analyst unavailable | $68 | $65.94 | -21.7% | Apr 26, 2022 |
| Cowen & Co. | Vivien Azer | $68 | $65.8 | -21.7% | Apr 26, 2022 |
| Credit Suisse | Kaumil Gajrawala | $68 | $65.05 | -21.7% | Apr 26, 2022 |
| Bank of America Securities | Bryan Spillane | $70 | $65.94 | -19.4% | Apr 25, 2022 |
| Guggenheim | Laurent Grandet | $71 | $65.94 | -18.2% | Apr 25, 2022 |
| CFRA | Garrett Nelson | $72 | $65.94 | -17.1% | Apr 25, 2022 |
| Cowen & Co. | Vivien Azer | $68 | $65.94 | -21.7% | Apr 25, 2022 |
| J.P. Morgan | Andrea Faria Teixeira | $73 | $65.25 | -15.9% | Apr 22, 2022 |
| Credit Suisse | Kaumil Gajrawala | $66 | $66.21 | -24.0% | Apr 21, 2022 |
| Evercore ISI | Robert Ottenstein | $70 | $62.54 | -19.4% | Feb 21, 2022 |
| Morgan Stanley | Dara Mohsenian | $76 | $60.29 | -12.5% | Feb 13, 2022 |
| UBS | Sean King | $68 | $59.83 | -21.7% | Feb 11, 2022 |
| Goldman Sachs | Bonnie Herzog | $60 | $60.91 | -30.9% | Feb 10, 2022 |
| Guggenheim | Laurent Grandet | $67 | $60.91 | -22.8% | Feb 10, 2022 |
| Credit Suisse | Kaumil Gajrawala | $66 | $59.15 | -24.0% | Jan 26, 2022 |
| CFRA | Garrett Nelson | $68 | $59.83 | -21.7% | Jan 4, 2022 |
| Bank of America Securities | Bryan Spillane | $64 | $55.19 | -26.3% | Jul 22, 2021 |
| Cowen & Co. | Vivien Azer | $60 | $55.27 | -30.9% | Jul 21, 2021 |
| Argus Research | Chris Graja | $63 | $53.71 | -27.5% | Jun 17, 2021 |
| DZ BANK AG | Axel Herlinghaus | $60 | $52.98 | -30.9% | Apr 21, 2021 |
Track every rating change on KO the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationThe Coca-Cola Company, a beverage company, manufactures and sells various nonalcoholic beverages in the United States and internationally. The company provides Trademark Coca-Cola, sparkling soft drinks and flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and emerging beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers comprising restaurants and convenience stores.…
Historical context
All KO earningsConsumer Defensive peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| COST Costco Wholesale Corporation | FY2026 Q4 · Calendar Q3 2026 | +3.2% | +2.9% | Costco’s growth broadens as warehouses and digital sales accelerate |
| GIS General Mills, Inc. | FY2027 Q1 · Calendar Q3 2026 | +4.6% | +1.0% | General Mills leans on mix, innovation and e-commerce amid pressure |
| KR The Kroger Co. | FY2026 Q2 · Calendar Q3 2026 | +2.8% | +2.7% | Kroger: Strong digital growth offsets softer sales outlook |
| CPB Campbell Soup Company | FY2026 Q4 · Calendar Q3 2026 | +1.1% | -7.0% | Campbell’s leans on savings and innovation amid pressured demand |
| BF-A Brown-Forman Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | — | Brown-Forman holds FY27 outlook as RTD innovation offsets barrel pressure |
| BF-B Brown-Forman Corporation | FY2027 Q1 · Calendar Q3 2026 | 0.0% | — | Brown-Forman maintains FY27 outlook as innovation offsets pressure |
Latest beats and misses
Who reports nextBeat on EPS
- CCLFY2026 Q3 · September 29, 2026+5.9% EPS+13.4% move
- COSTFY2026 Q4 · September 24, 2026+3.2% EPS+2.9% move
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
Get the KO recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:36:15.940040+00:00
- Polygon adjusted daily market bars · 2026-09-30T08:26:05.352420+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-30T08:26:05.349549+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-30. For educational purposes only; not investment advice.